世界の胃がん診断市場：製品タイプ別（試薬および消耗品および機器）、疾患タイプ別（腺がん、胃リンパ腫など）、エンドユーザー別（病院、腫瘍専門クリニック、診断研究所、がん研究所など）の分析、地域規模別、およびCOVID-19の影響による動向と2028年までの予測
胃がんの診断には、臨床評価、内視鏡検査やCTスキャンなどの画像検査、組織検査のための生検、特定のマーカーを検出するための血液検査を通じて胃がんを特定する包括的なプロセスが含まれます。胃がん診断の成長を促進する主な目的の1 つは、早期発見に重点を置くことです。早期段階での特定により、タイムリーな介入と治療が可能になり、予後と治療結果が大幅に改善されます。2022 年の世界の胃がん診断市場は 14 億 6000 万ドルで、2028 年までに 22 億 5000 万ドルに達すると予想されます。
胃がん診断の需要の増加を促進する顕著な要因の 1 つは、世界中で胃がんの発生率が増加していることと、胃がんの予防に対する人々の意識の高まりが挙げられます。特に高リスクの人々の間で、予防医療と定期検査の重要性が高まっており、市場の拡大を推進していますさらに、政府の支援的な取り組み、医療インフラの開発、研究開発活動の急増が、診断手順を合理化し、全体的な効率を向上させることによって市場の成長に貢献しています。さらに、高齢者人口が増加し、リキッドバイオプシーなどのイノベーション、画像技術や分子診断の改良などの先端技術、AIとヘルスケアの統合などの普及が進むにつれて、胃がん診断市場は成長が予測されます。世界の胃がん診断市場価値は、2023年から2028年の予測期間中に7.46%のCAGRで成長する見込みです。
目次
1. Executive Summary
2. Introduction
2.1 Gastric Cancer Diagnostic: An Overview
2.1.1 Introduction to Gastric Cancer Diagnostic
2.1.2 Ways to Reduce Gastric Cancer Risk
2.2 Gastric Cancer Diagnostic Segmentation: An Overview
2.2.1 Gastric Cancer Diagnostic Segmentation
3. Global Market Analysis
3.1 Global Gastric Cancer Diagnostic Market: An Analysis
3.1.1 Global Gastric Cancer Diagnostic Market: An Overview
3.1.2 Global Gastric Cancer Diagnostic Market by Value
3.1.3 Global Gastric Cancer Diagnostic Market by Product Type (Reagents & Consumables and Instruments)
3.1.4 Global Gastric Cancer Diagnostic Market by Disease Type (Adenocarcinoma, Gastric Lymphoma and Others)
3.1.5 Global Gastric Cancer Diagnostic Market by End User (Hospitals, Diagnostic Labs, Oncology Specialty Clinics, Cancer Research Institutes and Others)
3.1.6 Global Gastric Cancer Diagnostic Market by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)
3.2 Global Gastric Cancer Diagnostic Market: Product Type Analysis
3.2.1 Global Gastric Cancer Diagnostic Market: Product Type Overview
3.2.2 Global Reagents & Consumables Gastric Cancer Diagnostic Market by Value
3.2.3 Global Instruments Gastric Cancer Diagnostic Market by Value
3.3 Global Gastric Cancer Diagnostic Market: Disease Type Analysis
3.3.1 Global Gastric Cancer Diagnostic Market: Disease Type Overview
3.3.2 Global Adenocarcinoma Gastric Cancer Diagnostic Market by Value
3.3.3 Global Lymphoma Gastric Cancer Diagnostic Market by Value
3.3.4 Global Other Gastric Cancer Diagnostic Market by Value
3.4 Global Gastric Cancer Diagnostic Market: End User Analysis
3.4.1 Global Gastric Cancer Diagnostic Market: End User Overview
3.4.2 Global Hospitals Gastric Cancer Diagnostic Market by Value
3.4.3 Global Oncology Specialty Clinics Gastric Cancer Diagnostic Market by Value
3.4.4 Global Diagnostic Labs Gastric Cancer Diagnostic Market by Value
3.4.5 Global Cancer Research Institutes Gastric Cancer Diagnostic Market by Value
3.4.6 Global Others Gastric Cancer Diagnostic Market by Value
4. Regional Market Analysis
4.1 North America Gastric Cancer Diagnostic Market: An Analysis
4.1.1 North America Gastric Cancer Diagnostic Market: An Overview
4.1.2 North America Gastric Cancer Diagnostic Market by Value
4.1.3 North America Gastric Cancer Diagnostic Market by Region (The US, Canada and Mexico)
4.1.4 The US Gastric Cancer Diagnostic Market by Value
4.1.5 Canada Gastric Cancer Diagnostic Market by Value
4.1.6 Mexico Gastric Cancer Diagnostic Market by Value
4.2 Europe Gastric Cancer Diagnostic Market: An Analysis
4.2.1 Europe Gastric Cancer Diagnostic Market: An Overview
4.2.2 Europe Gastric Cancer Diagnostic Market by Value
4.2.3 Europe Gastric Cancer Diagnostic Market by Region (Germany, UK, France, Italy, Spain and Rest of the Europe)
4.2.4 Germany Gastric Cancer Diagnostic Market by Value
4.2.5 UK Gastric Cancer Diagnostic Market by Value
4.2.6 France Gastric Cancer Diagnostic Market by Value
4.2.7 Italy Gastric Cancer Diagnostic Market by Value
4.2.8 Spain Gastric Cancer Diagnostic Market by Value
4.2.9 Rest of Europe Gastric Cancer Diagnostic Market by Value
4.3 Asia Pacific Gastric Cancer Diagnostic Market: An Analysis
4.3.1 Asia Pacific Gastric Cancer Diagnostic Market: An Overview
4.3.2 Asia Pacific Gastric Cancer Diagnostic Market by Value
4.3.3 Asia Pacific Gastric Cancer Diagnostic Market by Region (China, India, South Korea, Japan and Rest of Asia Pacific)
4.3.4 China Gastric Cancer Diagnostic Market by Value
4.3.5 Japan Gastric Cancer Diagnostic Market by Value
4.3.6 India Gastric Cancer Diagnostic Market by Value
4.3.7 South Korea Gastric Cancer Diagnostic Market by Value
4.3.8 Rest of Asia Pacific Gastric Cancer Diagnostic Market by Value
4.4 Latin America Gastric Cancer Diagnostic Market: An Analysis
4.4.1 Latin America Gastric Cancer Diagnostic Market: An Overview
4.4.2 Latin America Gastric Cancer Diagnostic Market by Value
4.5 Middle East and Africa Gastric Cancer Diagnostic Market: An Analysis
4.5.1 Middle East and Africa Gastric Cancer Diagnostic Market: An Overview
4.5.2 Middle East and Africa Gastric Cancer Diagnostic Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Gastric Cancer Diagnostic Market
5.2 Post COVID-19 Impact on Gastric Cancer Diagnostic Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increase in the Global Geriatric Population
6.1.2 Rising Prevalence of Gastric Cancer
6.1.3 Growing Healthcare Expenditure
6.1.4 Amplified Disposable Income
6.1.5 Rising Awareness about Gastric Cancer
6.2 Challenges
6.2.1 High Diagnostic Cost
6.2.2 Shortage of Medical Laboratory Professionals
6.3 Market Trends
6.3.1 Rise in Adoption of Artificial Intelligence
6.3.2 Liquid Biopsy
6.3.3 Technological Advancements
7. Competitive Landscape
7.1 Global Gastric Cancer Diagnostic Market Players: Financial Comparison
8. Company Profiles
8.1 Agilent Technologies, Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Abbott Laboratories
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 Qiagen
8.3.1 Business Overview
8.3.2 Operating Regions
8.3.3 Business Strategy
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Roche Holdings AG
8.5.1 Business Overview
8.5.2 Operating Segment
8.5.3 Business Strategy
8.6 BIOMÉRIEUX S.A.
8.6.1 Business Overview
8.6.2 Sales by Application
8.6.3 Business Strategy
8.7 Illumina, Inc.
8.7.1 Business Overview
8.7.2 Operating Revenue
8.7.3 Business Strategy
8.8 Myriad Genetics, Inc.
8.8.1 Business Overview
8.8.2 Business Strategy
8.9 MIRXES PTE. LTD.
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 Vela Diagnostics Pte Ltd
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Advacare Pharma USA
8.11.1 Business Overview
List of Figures
Figure 1: Ways to Reduce Gastric Cancer Risk
Figure 2: Gastric Cancer Diagnostic Segmentation
Figure 3: Global Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Gastric Cancer Diagnostic Market by Product Type; 2022 (Percentage, %)
Figure 6: Global Gastric Cancer Diagnostic Market by Disease Type; 2022 (Percentage, %)
Figure 7: Global Gastric Cancer Diagnostic Market by End User; 2022 (Percentage, %)
Figure 8: Global Gastric Cancer Diagnostic Market by Region; 2022 (Percentage, %)
Figure 9: Global Reagents & Consumables Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 10: Global Reagents & Consumables Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Billion)
Figure 11: Global Instruments Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 12: Global Instruments Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 13: Global Adenocarcinoma Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Billion)
Figure 14: Global Adenocarcinoma Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Billion)
Figure 15: Global Lymphoma Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 16: Global Lymphoma Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 17: Global Other Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 18: Global Other Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 19: Global Hospitals Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 20: Global Hospitals Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 21: Global Oncology Specialty Clinics Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 22: Global Oncology Specialty Clinics Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 23: Global Diagnostic Labs Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 24: Global Diagnostic Labs Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 25: Global Cancer Research Institutes Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 26: Global Cancer Research Institutes Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 27: Global Others Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 28: Global Others Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 29: North America Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 30: North America Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 31: North America Gastric Cancer Diagnostic Market by Region; 2022 (Percentage, %)
Figure 32: The US Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 33: The US Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 34: Canada Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 35: Canada Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 36: Mexico Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 37: Mexico Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 38: Europe Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 39: Europe Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 40: Europe Gastric Cancer Diagnostic Market by Region; 2022 (Percentage, %)
Figure 41: Germany Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 42: Germany Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 43: UK Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 44: UK Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 45: France Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 46: France Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 47: Italy Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 48: Italy Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 49: Spain Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 50: Spain Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 51: Rest of Europe Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 52: Rest of Europe Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Billion)
Figure 53: Asia Pacific Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 54: Asia Pacific Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 55: Asia Pacific Gastric Cancer Diagnostic Market by Region; 2022 (Percentage, %)
Figure 56: China Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 57: China Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 58: Japan Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 59: Japan Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 60: India Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 61: India Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 62: South Korea Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 63: South Korea Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 64: Rest of Asia Pacific Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 65: Rest of Asia Pacific Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Billion)
Figure 66: Latin America Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 67: Latin America Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 68: Middle East and Africa Gastric Cancer Diagnostic Market by Value; 2018-2022 (US$ Million)
Figure 69: Middle East and Africa Gastric Cancer Diagnostic Market by Value; 2023-2028 (US$ Million)
Figure 70: Global Percentage of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 71: The US Number of New Stomach Cancer; 2018-2023 (Case Count)
Figure 72: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 73: Global GNI per Capita; 2016-2022 (US$ Thousand)
Figure 74: Global Artificial Intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
Figure 75: Agilent Technologies, Inc. Revenue by Segments; 2022 (Percentage, %)
Figure 76: Abbott Laboratories Sales by Segments; 2022 (Percentage, %)
Figure 77: Qiagen Net Sales by Regions; 2022 (Percentage, %)
Figure 78: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2022 (Percentage, %)
Figure 79: Roche Holdings AG Sales by Operating Segment; 2022 (Percentage, %)
Figure 80: BIOMÉRIEUX S.A. Sales by Application; 2022 (Percentage, %)
Figure 81: Illumina Revenue by Segments; 2022(Percentage, %)
Table 1: Global Gastric Cancer Diagnostic Market Players: Financial Comparison
